Shares of Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) have been given an average recommendation of “Hold” by the six ratings firms that are currently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average […]
Related Keywords
, Susquehanna International Group , Oncternal Therapeutics Inc , Richmond Brothers Inc , Oncternal Therapeutics Company Profile , Pasadena Private Wealth , Renaissance Technologies , Nasdaq , Ci Private Wealth , Oncternal Therapeutics , Get Free Report , Capital Management , Therapeutics Trading Down , Private Wealth , International Group , Get Free , Orphan Receptor , Oncternal Therapeutics Daily , Nasdaq Onct , Conct , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.